More on ALGS

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+24.8% Growth)
- Ratings (8.0 Score)

Upcoming Events

- Earnings (7/30/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Aligos Therapeutics Inc. (NQ:ALGS)
Delayed: 5.58 -0.07 (1.24%)
Prev. Close $5.65  
Open$5.54 
52 Wk High$ 
52 Wk Low$ 
Day High$5.76 
Day Low$5.35 
P/E N/A  
EPS$ 
Volume41,794 


Jun 24, 2026 04:31 PM Form SCHEDULE 13D Aligos Therapeutics, Filed by: BLATT LAWRENCE
May 29, 2026 07:30 AM Aligos Therapeutics (ALGS) Reiterated at Overweight by Cantor Fitzgerald
May 28, 2026 07:30 AM Lake Street Starts Aligos Therapeutics Inc. (ALGS) at Buy
May 27, 2026 04:05 AM Aligos presents hepatitis B drug data at liver conference
May 27, 2026 02:30 AM Aligos Therapeutics Presents Positive Data at the EASL Congress 2026
May 21, 2026 06:09 AM Cantor Fitzgerald Starts Aligos Therapeutics Inc. (ALGS) at Overweight
May 15, 2026 04:35 PM Form SCHEDULE 13G Aligos Therapeutics, Filed by: BLATT LAWRENCE
May 15, 2026 09:06 AM Form SCHEDULE 13G/A Aligos Therapeutics, Filed by: Woodline Partners LP
May 13, 2026 02:05 AM Aligos Therapeutics Announces Ten Abstracts Accepted for Presentation at the EASL Congress 2026
May 8, 2026 05:38 AM Aligos Therapeutics Inc. (ALGS) Misses Q1 EPS by 221c
View All Articles

Entities mentioned with ALGS

View All Entities